| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/03/2004 | EP1392651A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 03/03/2004 | EP1392648A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors |
| 03/03/2004 | EP1392645A2 Aza hydroxylated ethyl amine compounds |
| 03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 03/03/2004 | EP1392643A2 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392623A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 03/03/2004 | EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 03/03/2004 | EP1392365A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 03/03/2004 | EP1392363A2 Compositions and uses of mglur5 antagonists |
| 03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
| 03/03/2004 | EP1392348A1 Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 03/03/2004 | EP1392347A2 Method of preventing cell death using segments of neural thread proteins |
| 03/03/2004 | EP1392340A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 03/03/2004 | EP1392336A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| 03/03/2004 | EP1392334A2 Therapeutic methods using herbal compositions |
| 03/03/2004 | EP1392326A1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 03/03/2004 | EP1392320A1 17-METHYLENE-ANDROSTAN-3a-OL ANALOGS AS CRH INHIBITORS |
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392316A1 Benzo[d]azepine derivatives as 5-ht6 receptor antagonists. |
| 03/03/2004 | EP1392315A1 Methods of treating alzheimer's disease |
| 03/03/2004 | EP1392314A1 Novel use of 2-phenyl-substituted imidazotriazinones |
| 03/03/2004 | EP1392312A1 TRIAZOLO 4,5-d] PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 03/03/2004 | EP1392311A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 03/03/2004 | EP1392309A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 03/03/2004 | EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 03/03/2004 | EP1392306A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 03/03/2004 | EP1392305A2 Methods for treating neurodegenerative diseases including alzheimer's |
| 03/03/2004 | EP1392302A1 5-substituted-2-arylpyridines as crf1 modulators |
| 03/03/2004 | EP1392301A2 Prevention of addiction in pain management |
| 03/03/2004 | EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
| 03/03/2004 | EP1392298A2 Fused heterocyclic compounds |
| 03/03/2004 | EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases |
| 03/03/2004 | EP1392291A2 Tripeptidyl peptidase inhibitors |
| 03/03/2004 | EP1392289A2 Caspase inhibitors and uses thereof |
| 03/03/2004 | EP1392287A2 Use of azetidinone substituted derivatives in the treatment of alzheimer's disease |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | EP1392276A1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 03/03/2004 | EP1392275A1 Use of protein and essential amino acids to treat amenorrhea and related disorders |
| 03/03/2004 | EP1392273A1 Novel treatment for obsessive-compulsive disorder (ocd) and ocd-related disorders using gvg |
| 03/03/2004 | EP1392270A2 Abuse resistant pharmaceutical composition containing capsaicin |
| 03/03/2004 | EP1392265A2 Inhibitors of abc drug transporters at the blood-brain barrier |
| 03/03/2004 | EP1392264A1 Delivery of antiemetics through an inhalation route |
| 03/03/2004 | EP1392262A1 Delivery of drug esters through an inhalation route |
| 03/03/2004 | EP1392261A2 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 03/03/2004 | EP1392259A2 Delivery of erectile dysfunction drugs through an inhalation route |
| 03/03/2004 | EP1392258A2 Delivery of alprazolam, estazolam, midazolam or triazolam throughan inhalation route |
| 03/03/2004 | EP1392257A1 Delivery of antihistamines through an inhalation route |
| 03/03/2004 | EP1392256A1 Improved transdermal therapeutic system for the treatment of parkinson's disese |
| 03/03/2004 | EP1392255A1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
| 03/03/2004 | EP1392250A2 Controlled release dosage forms using acrylic polymer, and process for making the same |
| 03/03/2004 | EP1392249A1 Nsaid formulation comprising a granular composition and an extra-granular composition |
| 03/03/2004 | EP1392247A2 Process for preparing granular compositions |
| 03/03/2004 | EP1392246A1 Compaction process for manufacture of sodium phenytoin dosage form |
| 03/03/2004 | EP1392241A2 System for osmotic delivery of pharmaceutically active agents |
| 03/03/2004 | EP1392133A2 Functional agent for decomposing nicotine and method of preparing the same |
| 03/03/2004 | EP1284974B1 Triazolyl tropane derivatives as ccr5 modulators |
| 03/03/2004 | EP1282624B1 Crf receptor antagonists and methods relating thereto |
| 03/03/2004 | EP1202717B1 Use of naaladase inhibitors for treating anxiety and memory disorders |
| 03/03/2004 | EP1196440B1 Therapeutic peptides derived from subsequences of bpi |
| 03/03/2004 | EP1047437A4 Sea cucumber carotenoid lipid fraction products and methods of use |
| 03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
| 03/03/2004 | EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy |
| 03/03/2004 | EP1037615B1 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 03/03/2004 | EP0998460B1 Novel tetrazole derivatives |
| 03/03/2004 | EP0853617B1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 03/03/2004 | CN1479740A Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines |
| 03/03/2004 | CN1479739A Heterocyclic ether substituted imidazoquinolie compounds |
| 03/03/2004 | CN1479738A Thioether subsituted imidazoquinoline compound |
| 03/03/2004 | CN1479736A Benzofuran and benzothiophene derivatives |
| 03/03/2004 | CN1479727A Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479620A Oral extended release formulation of gepirone |
| 03/03/2004 | CN1479619A Use of pyrazolo [4,3-d] pyrimidines |
| 03/03/2004 | CN1479617A N-methyl-D-aspartate receptor agonist pharmaceutical compositions |
| 03/03/2004 | CN1479616A Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers |
| 03/03/2004 | CN1479614A Controlled release hydrocodone formulations |
| 03/03/2004 | CN1478534A Longgong (scorpion and ground beetle) pain relieving capsule |
| 03/03/2004 | CN1478532A Sobering and liver protecting liquid product and its production method |
| 03/03/2004 | CN1478531A Chinese medicinal composition for treating epilepsy disease and its preparation method |
| 03/03/2004 | CN1478521A Medicine for relaxing muscles and tendons and activiating colleterals and pain dispelling |
| 03/03/2004 | CN1478511A Application of crude medicinal material in the preparation of medicine for treating dyssomnia |
| 03/03/2004 | CN1478506A Medicine for treating depression |
| 03/03/2004 | CN1478498A Medicine for treating senile dementia |
| 03/03/2004 | CN1478482A Slow release (controlled releuse) preparation of doufuguosu |
| 03/03/2004 | CN1140526C 8-azabicyclo[3,2,1] octane-3-methanamine derivatives as ligands of D2 and D3 doppamine and 5HT1A and 5HT2 serotonin receptors |
| 03/03/2004 | CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 03/03/2004 | CN1140524C 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders |
| 03/03/2004 | CN1140521C Method for preparation of citalopram |
| 03/03/2004 | CN1140509C Novel vitamin D. analogues |
| 03/03/2004 | CN1140500C Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 03/03/2004 | CN1140294C Use of VIP, analogues and fragments thereof for the treatment of neurodegemeratiue diseases |
| 03/03/2004 | CN1140293C Pain-relieving capsule and its prepn. process |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699903 Hydration of the anhydrous lithium salt with acetonitrile and water; phosphodiesterase inhibitors |
| 03/02/2004 | US6699893 Glucocorticoid receptor modulators |
| 03/02/2004 | US6699888 Antiinflammatory |
| 03/02/2004 | US6699880 Substituted imidazolidinone derivatives |
| 03/02/2004 | US6699879 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |